MELISSA BROWN: Open Payments
NPI 1437732138 · TULLAHOMA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$768 in 18 payments from 9 companies in 2025. Trend: 2023 $48 · 2024 $489 · 2025 $768
Food & beverage: $768
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $163 |
| Novo Nordisk Inc | 2 | $144 |
| ABBVIE INC. | 3 | $141 |
| Boston Scientific Corporation | 1 | $123 |
| Axsome Therapeutics, Inc. | 3 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $52 |
| Exact Sciences Corporation | 2 | $36 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
Products named: BREZTRI, Ozempic, QULIPTA, WaveWriter Alpha Prime 16, Auvelity, CAPLYTA, Cologuard Collection Kit, RECORLEV.
Industry payments across TN — which companies pay providers there.
